MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Dextroamphetamine

Selected References:

  • Anderson KN, et al. 2020. ADHD medication use during pregnancy and risk for selected birth defects: national birth defects prevention study, 1998-2011. J Atten Disord, 24(3):479-489.
  • Cohen JM, et al. 2017. Placental complications associated with psychostimulant use in pregnancy. Obstet Gynecol, 130(6):1192-1201.
  • Golub M, et al. 2005. NTP CERHR expert panel report on the reproductive and developmental toxicity of amphetamine and methamphetamine. Birth Defects Res B Dev Reprod Toxicol, 74(6):471-584.
  • Huybrechts KF, et al. 2018. Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: a cohort study from the international pregnancy safety study consortium. JAMA Psychiatry, 75(2):167-175.
  • Ilett KF, et al. 2007. Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder. Br J Clin Pharmacol, 63(3):371-375.
  • Naeye RL, 1983. Maternal use of dextroamphetamine and growth of the fetus. Pharmacology, 26(2):117-120.
  • Ornoy A, 2018. Pharmacological treatment of attention deficit hyperactivity disorder during pregnancy and lactation. Pharm Res, 35:46.
  • Rose SJ, et al. 2020. Amphetamine–dextroamphetamine and pregnancy: neonatal outcomes after prenatal prescription mixed amphetamine exposure. Journal of Attention Disorders, 25(9):1295-1301.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.